ArticleThe Gerontologist2025
The validity of Blue Zones demography: a response to critiques.
Article in The Gerontologist, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Editorial: Alleviating age-related disease burden.Frontiers in aging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Blue Zones are geographically and temporally defined areas with a history of disproportionately high concentrations of nonagenarians and centenarians. Nearly two decades ago, these zones gained international attention when the Blue Zone term was introduced in seminal articles published in Experimental Gerontology and National Geographic. Since then, numerous scientific papers have extracted valuable insights into human health from investigating the long-lived people who live there. However recently, validity of the ages of people living in the Blue Zones has been questioned. Here, we address these concerns by describing in detail the age validation process undertaken in Blue Zones and comparing it to the prevailing standards in gerontological demography. As discovered a century and a half ago, most self-reported claims of exceptional longevity are false. However, using methods developed by gerontological demographers over the past decades, the true age of people claiming exceptional longevity can be determined by cross-checking multiple independent documentary sources. This procedure minimizes, and usually eliminates, errors due to fraud, honest mistakes, poor memory, or identity switches, especially between homonymous siblings. All Blue Zones described herein have been extensively validated based on thoroughly cross-checked data from multiple independent sources plus state-of-the-art demographic methods. Consequently, age data from these Blue Zones are valid and reliable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.